Low-dose antiprogestin treatment prevents pregnancy in rhesus monkeys and is reversible after 1 year of treatment

Human Reproduction

Volumn 18, Issue 1, 2003, Pages 69-76

  Borman, S M ^a   Schwinof, K M ^a   Niemeyer, C ^a   Chwalisz, K ^b,d   Stouffer, R L ^a,c   Zelinski Wooten, M B ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b BAYER PHARMA AG   (Germany)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d TAP Pharmaceuticals   (United States)

Author keywords

Antiprogestin; Contraception; Pregnancy; Reversibility; ZK 137 316

Indexed keywords

ANTIGESTAGEN; CONTRACEPTIVE AGENT; ZK 137 316;

ANIMAL EXPERIMENT; ARTICLE; BIRTH RATE; BIRTH WEIGHT; CELL PROLIFERATION; COITUS; CONCEPTION; CONTRACEPTION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOMETRIUM; FEASIBILITY STUDY; FEMALE; FEMALE FERTILITY; GESTATION PERIOD; LOW DRUG DOSE; MALE; MALE FERTILITY; MATING; MENSTRUAL CYCLE; NONHUMAN; OVARY CYCLE; PREGNANCY; PREGNANCY RATE; PROGENY; RHESUS MONKEY; SPERM; TREATMENT PLANNING; VAGINA;

ANIMALIA; MACACA MULATTA;

EID: 0037251493     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg014     Document Type: Article

References (29)

1. Batista, M.D., Cartledge, T.P. and Zellmer, A.W. (1992) Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: A potential new contraceptive strategy. Am. J. Obstet. Gynecol., 167, 60-65.
2. Brown, A., May, A., Smith, K.B. Cheng, L., Lin, S. and Baird, D. (2000) Daily low dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: A study over four months in Edinburgh and Shanghai. In Program of the FIGO World Congress of Gynecology and Obstetrics, Washington, DC. Int. J. Gynaecol. Obstet., Abstract 71.
3. Brown, A, Cheng, L, Suiquing, L. and Barid, T. (2002) Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: A double blind randomized control trial of 2 and 5 mg per day for 120 days. J. Clin. Endocrinol. Metab., 87, 63-70.
4. Buchl, S.J. and Howard, B. (1997) Hematologic and serum biochemical and electrolyte values in clinically normal domestically bred rhesus monkeys (macaca mulatta) according to age, sex and gravidity. Lab. Anim. Sci., 47, 528-533.
5. Bygdeman, M, Gemzell Danielsson, K, Marions, L. and Swahn, M.L. (1999) Contraceptive use of antiprogestin. Eur. J. Contracept. Reprod. Health Care, 4, 103-107.
6. Cameron, S.T., Thong, K.J. and Baird, D.T. (1995) Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth. Clin. Endocrinol., 43, 407-414.
7. Cameron, S.T., Critchley, H.O.D., Thong, K.J., Buckley, C.H., Williams, A.R. and Baird, D.T. (1996) Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum. Reprod., 11, 2518-2526.
8. Chwalisz, K., Brenner, R.M., Fuhrmann, U.U., Hess-Stump, H. and Elger, W. (2000) Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium. Steroids, 65, 741-751.
9. Croxatto, H.B., Salvatierra, A.M., Croxatto, H.D. and Fuentealba, B. (1993) Effects of continuous treatment with low-dose mifepristone throughout one menstrual cycle. Hum. Reprod., 8, 201-207.
10. Durand, S., Chevalier, G., Verschuere, B., Bengone, T. and Benard, P. (1998) Plasma lipid parameters in Macaca fascicularis bred in Mauritius: A biochemical study. Folia Primatol., 69, 54.
11. Fernie, S., Wrenshall, E., Malcolm, S., Bryce, F. and Arnold, D.L. (1994) Normative hematologic and serum biochemical values for adult and infant rhesus monkeys (Macaca mulatta) in a controlled laboratory environment. J. Toxicol. Environ. Health, 42, 53-72.
12. Gemzell-Danielsson, K., Swahn, M.L., Svalander, P. and Bygedman, M. (1993) Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum. Reprod., 8, 870-873.
13. Gemzell-Danielsson, K., Westlund, P., Johannisson, E, Swahn, M.L., Bygdeman, M. and Seppala, M. (1996) Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum. Reprod., 11, 256-264.
14. Gemzell-Danielsson, K., Swahn, M.L., Westlund, P., Johannisson, E., Seppala, M. and Bygdeman, M. (1997) Effect of low daily doses of mifepristone on ovarian function and endometrial development. Hum. Reprod., 12, 124-131.
15. Ghosh, D., Luther, P.G. and Kumar, L. (1997) Early luteal phase administration of mifepristone inhibits preimplantation embryo development and viability in the rhesus monkey. Hum. Reprod. 12, 575-582.
16. Katkam, R.R., Gopalkrishnan, K., Chwalisz, K., Schillinger, E. and Puri, C.P. (1995) Onapristone (ZK 98.299): A potential antiprogestin for endometrial contraception. Am. J. Obstet. Gynecol., 173, 779-787.
17. Kettel, L.M., Greene, K. and Yen, S.S.C. (1992) Endometrial dyssynchronization without hormonal changes by the antiprogesterone RU 486 during the luteal phase of the menstrual cycle: A contraceptive potential. In Program of the 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, Texas Abstract 88.
18. Marions, L., Danielsson, K.G., Swan, M.L. and Bygdeman, M. (1998) Contraceptive efficacy of low doses of mifepristone. Fertil. Steril., 70, 813-816.
19. Marions, L., Viski, S, Danielsson, K.G., Resch, B.A., Swahn, M.L., Bygdeman, M. and Kovacs, L. (1999) Contraceptive efficacy of daily administration of 0.5 mg mifepristone. Hum. Reprod., 14, 2788-2790.
20. McDonnell, D.P. (1995) Unraveling the human progesterone receptor signal transduction pathway. Insights into antiprogestin action. Trends Endocrinol. Metab., 4, 133-138.
21. Slayden, O.D. and Brenner, R.M. (1994) RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mlatta). J. Clin. Endocrinol. Metab., 78, 440-448.
22. Slayden, O.D., Zelinski-Wooten, M.B., Chwalisz, K., Brenner, R.M. and Stouffer, R.L. (1998) Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316. Dose-dependent endometrial atrophy. Hum. Reprod., 13, 269-277.
23. Slayden, O.D., Chwalisz, K. and Brenner, R.M. (2001a) Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. Hum. Reprod., 16, 1562-1574.
24. Slayden, O.D., Chwalisz, K., Burton, K.A.C.S.T., Nayak, N.R. and Critchley, H.O.D. (2001b) Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J. Clin. Endocrinol. Metab., 86, 2668-2679.
25. Takenaka, A, Matsumoto, Y, Nagaya, A., Watanabe, L., Goto, S., Suryobroto, B. and Takenada, O. (2000) Plasma cholesterol levels in free-ranging macaques compared with captive macaques and humans. Primates, 41, 299-309.
26. Tarantal, A.F. and Hendrickz, A.G. (1988) Prenatal growth in the cynomolgus and rhesus macaque (macaca fascicularis and macaca mulatta): A comparison by ultrasonography. Am. J. Primatol., 15, 309-323.
27. Van Look, P.F.A. and Von Hertzen, H. (1995) Clinical uses of antiprogestins. Hum. Reprod. Update, 1, 19-34.
28. Zelinski-Wooten, M.B., Slayden, O.D., Chwalisz, K., Hess, D.L., Brenner, R.M. and Stouffer, R.M. (1998a) Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 136: Establishment of a regimen that permits normal menstrual cyclicity. Hum. Reprod., 13, 259-267.
29. Zelinski-Wooten, M.B., Chwalisz, K., Illiff, S.A., Niemyer, C., Eaton, G., Loriaux, D.L., Slayden, O.D., Brenner, R.M. and Stouffer, R.L. (1998b) A chronic, low dose regimen of the antiprogestin ZK 137 316 prevents pregnancy in rhesus monkeys. Hum. Reprod., 13, 2132-2138.